| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.088 | 0.04 |